Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ Research Priorities Should Include Quality Of Cardiovascular Care, Guidant Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency should research a potential disparity in cardiovascular care between men and women, and the clinical and economic benefits of early screening for carotid artery disease, Guidant says. The device industry has also raised new technology underutilization and e-health as potential topics.
Advertisement

Related Content

Pfizer, Novartis Learning The VALUE Of Comparative Research
Pfizer, Novartis Learning The VALUE Of Comparative Research
AHRQ Rx Comparisons Should Focus On Existing Literature, Not Clinical Trials, McClellan Says
AHRQ Comparative Research Should Focus On Diseases, Not Drug Classes, PhRMA Says
Comparative Research Should Start With Rx Drugs, AHRQ Says
Comparative Research Should Start With Rx Drugs, AHRQ Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS059508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel